MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1729, Issue 1, 2005, Pages 41-49

  Kopacek, Juraj ^a,b   Barathova, Monika ^a   Dequiedt, Franck ^c   Sepelakova, Janka ^a   Kettmann, Richard ^c   Pastorek, Jaromir ^a   Pastorekova, Silvia ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Carbonic anhydrase IX; Cell density; Hypoxia; MAPK pathway; Promoter activity; Transcriptional regulation

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CARBONATE DEHYDRATASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CELL DENSITY; CONTROLLED STUDY; DENSITY; ENZYME INHIBITION; GENE CONTROL; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, NEOPLASM; BUTADIENES; CARBONIC ANHYDRASES; CELL COUNT; CELL HYPOXIA; CHROMONES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; NITRILES; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 19544381887     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2005.03.003     Document Type: Article

References (40)

1. C.T. Supuran Carbonic anhydrases: catalytic mechanisms, distribution and physiological roles C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase: Its Inhibitors and Activators 2004 CRC Press Boca Raton 1 24
2. S. Pastorekova, and J. Pastorek Cancer-related carbonic anhydrase isozymes and their inhibition C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase: Its Inhibitors and Activators 2004 CRC Press Boca Raton 253 272
3. C.P. Potter, and A.L. Harris Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer Br. J. Cancer 89 2003 2 7
4. E. Svastova, N. Zilka, M. Zatovicova, A. Gibadulinova, F. Ciampor, J. Pastorek, and S. Pastorekova Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin Exp. Cell Res. 290 2003 332 345
5. E. Svastova, A. Hulikova, M. Rafajova, M. Zatovicova, A. Gibadulinova, A. Casini, A. Cecchi, A. Scozzafava, C.T. Supuran, J. Pastorek, and S. Pastorekova Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH FEBS Lett. 577 2004 439 445
6. C.C. Wykoff, N.J.P. Beasley, P.H. Watson, K.J. Turner, J. Pastorek, A. Sibtain, G.D. Wilson, H. Turley, K.L. Talks, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe, and A.L. Harris Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res. 60 2000 7075 7083
7. J. Lieskovska, R. Opavsky, L. Zacikova, M. Glasova, J. Pastorek, and S. Pastorekova Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma Neoplasma 46 1999 17 24
8. S. Kaluz, M. Kaluzova, A. Chrastina, P.L. Olive, S. Pastorekova, J. Pastorek, M.I. Lerman, and E.J. Stanbridge Lowered oxygen tension induces expression of the hypoxia marker MN/Carbonic anhydrase IX in the absence of hypoxia-inducible factor 1α stabilization: a role for phosphatidylinositol 3′-kinase Cancer Res. 62 2002 4469 4477
9. S. Kaluz, M. Kaluzova, R. Opavsky, S. Pastorekova, A. Gibadulinova, F. Dequiedt, R. Kettmann, and J. Pastorek Transcriptional regulation of the MN/CA9 gene coding for the tumor-associated carbonic anhydrase IX J. Biol. Chem. 274 1999 32588 32595
10. M. Kaluzova, S. Pastorekova, E. Svastova, J. Pastorek, E.J. Stanbridge, and S. Kaluz Characterization of the MN/CA9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors Biochem. J. 359 2001 669 677
11. 2 sensing Science 292 2001 464 468
12. 2-regulated prolyl hydroxylation Science 292 2001 468 472
13. P.C. Mahon, K. Hirota, and G.L. Semenza FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity Genes Dev. 15 2001 2675 2686
14. G.L. Semenza Signal transduction to hypoxia-inducible factor 1 Biochem. Pharmacol. 64 2002 993 998
15. J. Bardos, and M. Ashcroft Hypoxia-inducible factor-1 and oncogenic signaling BioEssays 26 2004 262 269
16. E. Laughner, P. Taghavi, K. Chiles, P.C. Mahon, and G.L. Semenza HER2(neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol. Cell. Biol. 21 2001 3995 4004
17. D.E. Richard, E. Berra, E. Gothie, D. Roux, and J. Pouyssegur p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1 J. Biol. Chem. 274 1999 32631 32637
18. S. Kaluz, M. Kaluzova, and E.J. Stanbridge Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer Cancer Res. 63 2003 917 922
19. J. Milanini, F. Vinals, J. Pouyssegur, and G. Pages p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts J. Biol. Chem. 273 1998 18165 18172
20. E. Minet, T. Arnould, G. Michel, I. Roland, D. Mottet, M. Raes, J. Remacle, and C. Michiels ERK activation upon hypoxia: involvement in HIF-1 activation FEBS Lett. 468 2000 53 58
21. T. Hofer, I. Desbaillets, G. Hopfl, M. Gassmann, and R.H. Wenger Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1α activation cascade: implications for HIF-1α gene therapy FASEB J. 15 2001 2715 2717
22. S.M. Wood, M.S. Wiesener, K.M. Yeates, N. Okada, C.W. Pugh, P.H. Maxwell, and P.J. Ratcliffe Selection and analysis of a mutant cell line defective in the hypoxia inducible factor 1α subunit (HIF-1α) J. Biol. Chem. 273 1998 8360 8368
23. S. Pastorekova, Z. Zavadova, M. Kostal, O. Babusikova, and J. Zavada A novel quasi-viral agent, MaTu, is a two component system Virology 187 1992 620 626
24. J. Zavada, Z. Zavadova, J. Pastorek, Z. Biesova, J. Jezek, and J. Velek Human tumor-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion Br. J. Cancer 82 2000 1508 1513
25. T.S. Lewis, P.S. Shapiro, and N.G. Ahn Signal transduction through MAP kinase cascades Adv. Cancer Res. 74 1998 49 139
26. E. Berra, M.T. Diaz-Meco, and J. Moscat The activation of p38 and apoptosis by inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway J. Biol. Chem. 273 1998 10792 10797
27. J.J. Haddad Hypoxia and the regulation of mitogen-activated protein kinases: gene transcription and the assessment of potential pharmacologic therapeutic interventions Int. Immunopharmacol. 4 2004 1249 1285
28. P.J. Kallio, P. Okamoto, S. O'Brien, P. Carrero, Y. Makino, H. Tanaka, and L. Poellinger Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1aplha EMBO J. 17 1998 6573 6586
29. N. Sang, D.P. Stiehl, J. Bohensky, I. Leshchinsky, V. Srinivas, and J. Caro MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300 J. Biol. Chem. 278 2003 14013 14019
30. E.A. Sheta, H. Trout, J.J. Gildea, M.A. Harding, and D. Theodorescu Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAP kinase mediated signaling pathways Oncogene 20 2001 7624 7634
31. E. Berra, J. Milanini, D.E. Richard, M. Le Gall, F. Vinals, E. Gothie, D. Roux, G. Pages, and J. Pouyssegur Signaling angiogenesis via p42/p44 MAP kinase and hypoxia Biochem. Phamacol. 60 2000 1171 1178
32. H. Zhong, K. Chiles, D. Feldser, E. Laughner, E. Hanrahan, M.M. Georgescu, J.W. Simons, and G.L. Semenza Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/Akt/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics Cancer Res. 60 2000 1541 1545
33. B.H. Jiang, G. Jiang, J.Z. Zheng, Z. Lu, T. Hunter, and P.K. Vogt Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1 Cell Growth Differ. 12 2001 363 369
34. D.P. Stiehl, W. Jelkman, R.H. Wenger, and T. Hellwig-Burgel Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1α involves the phosphatidylinositol 3-kinase pathway FEBS Lett. 512 2002 157 162
35. B.H. Jiang, J.Z. Zheng, M. Aoki, and P.K. Vogt Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells Proc. Natl. Acad. Sci. U. S. A. 97 2000 1749 1753
36. A. Maity, N. Pore, J. Lee, D. Solomon, and D.M. O'Rourke Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3-kinase and distinct from that in hypoxia Cancer Res. 60 2000 5879 5886
37. Z.Y. Jiang, Z. He, B.L. King, T. Kuroki, D.M. Opland, K. Suzuma, I. Suzuma, K. Ueki, R.N. Kulkarni, C.R. Kahn, and G.L. King Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis J. Biol. Chem. 278 2003 31964 31967
38. G.W. Huang, L.Y. Yang, and W.Q. Lu Effects of PI3K and p42/p44 MAPK on overexpression of vascular endothelial growth factor in hepatocellular carcinoma World J. Gastroenterol. 10 2004 809 812
39. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat. Med. 10 2004 789 799
40. N. Robertson, C. Potter, and A.L. Harris Role of carbonic anhydrase IX in human tumor cell growth, survival and invasion Cancer Res. 64 2004 6160 6165